Skip to main content

Table 5 The hazard ratio (95% CI) of MetS for Hyper-CEA in subcohort B by stratified analysis

From: Bidirectional association between serum carcinoembryonic antigen and metabolic syndrome among the Chinese male population: two cohort studies

Characteristics

Model 1a

Model 2b

β

Hazard ratio (95% CI)

P

β

Hazard ratio (95% CI)

P

Age ≤ 45 y, nonsmoking (n = 3052)

 MetS

−0.081

0.92 (0.59, 1.44)

0.72

−0.165

0.85 (0.53, 1.35)

0.489

 Non-MetS

 

1

  

1

 

Age > 45 y and ≤ 65 y, nonsmoking (n = 1660)

 MetS

0.274

1.31 (0.92, 1.89)

0.137

0.338

1.40 (0.96, 2.05)

0.083

 Non-MetS

 

1

  

1

 

Age > 65 y, nonsmoking (n = 523)

 MetS

0.576

1.78 (1.08, 2.92)

0.023

0.626

1.87 (1.09, 3.20)

0.022

 Non-MetS

 

1

  

1

 

Age ≤ 45 y, smoking (n = 2000)

 MetS

−0.018

0.98 (0.66, 1.45)

0.929

−0.106

0.90 (0.59, 1.36)

0.616

 Non-MetS

 

1

  

1

 

Age > 45 y and ≤ 65 y, smoking (n = 1147)

 MetS

−0.332

0.72 (0.49, 1.06)

0.095

−0.316

0.73 (0.49, 1.09)

0.119

 Non-MetS

 

1

  

1

 

Age > 65 y, smoking (n = 104)

 MetS

−0.178

0.84 (0.3, 2.33)

0.733

−0.604

0.55 (0.14, 2.11)

0.38

 Non-MetS

 

1

  

1

 
  1. a: Model 1 was the unadjusted hazard ratio; b: Model 2 was adjusted for alanine aminotransferase, serum creatinine and white blood cell count. CEA Carcinoembryonic antigen; Hyper-CEA Elevated serum CEA level above the reference range; MetS Metabolic syndrome; Non-MetS Without metabolic syndrome